TB-500 Dosing & Protocols — Research Reference

TB-500 is a synthetic fragment of Thymosin Beta-4 widely studied in cell-migration, angiogenesis, and tissue-repair research. This guide compiles the loading-phase + maintenance-phase reference pattern common across published research.

Reconstitution for Research

TB-500 is supplied lyophilized. Standard reconstitution: 2–5 mg with 1–2 mL bacteriostatic water. Refrigerated stability extends 30+ days per COA.

Reference Dose Ranges in Published Research

| Research model tier | Typical range | Notes | |---|---|---| | Loading phase | 2–2.5 mg, twice weekly × 4–6 weeks | Most-cited loading pattern to reach tissue saturation | | Maintenance phase | 2 mg, once every 2 weeks | After loading; sustained-effect protocols | | Acute injury models | 5 mg, single dose followed by 2.5 mg weekly | Cited in acute-onset tissue-repair research |

Scheduling

Subcutaneous administration is most-cited; localized injection near target tissue is used in some musculoskeletal models. Half-life is short systemically, but the loading-phase pattern reflects the time required for tissue distribution and cumulative effect.

Cycling in the Published Literature

Distinct loading + maintenance cycling is the dominant research paradigm — unlike continuous-administration peptides. Loading lasts 4–6 weeks, then maintenance can extend for months without observed tolerance.

Common Research Endpoint Markers

Tissue tensile strength, cell-migration assays in vitro, capillary-density measurements (angiogenesis endpoints), inflammatory cytokine panels. Cardiac and dermal research tracks tissue-specific endpoints (ejection fraction, dermal density).

Common Research Pairings

Most-cited pairing is TB-500 + [BPC-157](/research/hubs/bpc-157) for complementary tissue-repair mechanisms. The BPC-157 cytoprotective + angiogenic profile complements TB-500's cell-migration profile.

Storage & Stability

Lyophilized at 2–8 °C protected from light. Reconstituted refrigerated; freeze-thaw should be minimized.

Frequently Asked Questions

Why use a loading phase?

TB-500 acts through actin-sequestration and cell-migration mechanisms that require cumulative tissue distribution. Loading saturates the relevant compartments faster than maintenance dosing alone.

Can TB-500 be administered IM near an injury?

Localized IM administration near a target tissue is used in some musculoskeletal research models, though the published systemic-SubQ literature is larger.

Research-Use Disclosure

All content is provided strictly for laboratory research purposes. Compounds discussed are research chemicals and are not for human or veterinary consumption. Dosing ranges referenced below are summaries of published preclinical and clinical research literature compiled for laboratory reference only — they are not medical recommendations.